Cancer Drug Effective in Relapsing MS (CME/CE)

NEW ORLEANS (MedPage Today) -- Alemtuzumab (Lemtrada, Campath) dramatically reduced multiple sclerosis relapses in patients with long-term disease -- with just once-a-year treatment, researchers reported here.

http://www.medpagetoday.com/MeetingCoverage/AANMeeting/32354

Sent with MobileRSS for iPhone

Júlio Leonardo B. Pereira

http://lattes.cnpq.br/7687651239699170

http://www.neurocirurgiabr.com